FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / formal-protest-draft-v3-client-review.docx
formal-protest-draft-v3-client-review.docx · 1018-00009

Parties

Penterra Pharmaceuticals Corp
Harkness LLP
OF PROTEST Penterra Pharmaceuticals Corp
Global Intangible Low-Taxed Inc
Associates LLP
PPC's Corp
Business Operations Penterra Pharmaceuticals Corp
Penterra Manufacturing Ireland Ltd

Dates

December 16, 2023
December 5, 2023
December 12, 2023
December 14, 2023
November 8, 2023
October 12, 2023
December 19, 2023
December 22, 2023
June 8, 2022
December 8, 2023

Amounts

$380,400,000
$235,010,000
$188,040,000
$42,650,000
$15,977,000
€47.2
€2.14
€1.06
$312,000,000
$814.6

Obligations

The principal requirements for a qualified CSA under the regulations include: (a) Eligibility of Controlled Participants: Each controlled participant must reasonably expect to derive benefits from the intangible development activity
(b) Scope of Intangible Development Activity: The CSA must define the intangible development activity that is the subject of cost sharing
(c) Reasonably Anticipated Benefits: Each participant's cost-sharing percentage must be determined based on that participant's share of the reasonably anticipated benefits from the intangible development activity
(d) Platform Contribution Transactions: When a controlled participant makes pre-existing resources, capabilities, or rights available to the CSA, the other participants must make arm's-length payments (platform contribution transaction payments) to compensate for such contributions
Both prongs must be satisfied
The proposed § 482 adjustments, to the extent they reduce PBI's income, would correspondingly reduce PPC's GILTI inclusion — an interaction that must be accounted for in computing the correct tax liability